Skip to content

Clinical trials

Phase 3 Febrile Neutropenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Febrile Neutropenia Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20081
20091
20111
20122
20131
20171
20181
20201
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status4
Not yet recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.2
Academisch Ziekenhuis Maastricht1
All India Institute of Medical Sciences1
Amgen1
Biocad1
Brigham and Women's Hospital1
Center for Supporting Hematology-Oncology Trials1
Fundación para la Investigación Biosanitaria del Principado de Asturias1
Lei Li1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Febrile Neutropenia16
Neutropenia5
Breast Neoplasms3
Neoplasms2
Carcinoma, Ovarian Epithelial1
Colonic Neoplasms1
Colorectal Neoplasms1
Fever1
Hematologic Diseases1
Hematologic Neoplasms1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.